Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes

Morbidity and mortality of immunocompromised patients are increased by primary infection with or reactivation of Epstein-Barr virus (EBV), possibly triggering EBV(+) post-transplant lymphoproliferative disease (PTLD). Adoptive transfer of EBV-specific cytotoxic T cells (EBV-CTLs) promises a non-toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieling, Maren, Tischer, Sabine, Kalinke, Ulrich, Blasczyk, Rainer, Buus, Søren, Maecker-Kolhoff, Britta, Eiz-Vesper, Britta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797009/
https://www.ncbi.nlm.nih.gov/pubmed/29435138
http://dx.doi.org/10.18632/oncotarget.23531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797009/
https://www.ncbi.nlm.nih.gov/pubmed/29435138
http://dx.doi.org/10.18632/oncotarget.23531

Ejemplares similares